在糖尿病前和糖尿病患者中,脂质乱管理策略 (2024)
Laura Gaita1,2, Bogdan Timar1,2, Romulus Timar1,2
1Second Department of Internal Medicine, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Pharmaceuticals (Basel, Switzerland)
|February 24, 2024
概括
失脂症是糖尿病和糖尿病前期心血管疾病的常见风险,需要有效的脂质管理. 本综述涵盖了改善脂质水平和降低心血管风险的当前治疗方法和指导方针.
科学领域:
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 失脂症是糖尿病和糖尿病前期患者动脉样硬化心血管疾病 (ASCVD) 的重要,可修改的危险因素.
- 有效管理脂质疾病对于预防心血管并发症至关重要.
研究的目的:
- 总结有关糖尿病或糖尿病前期患者脂质疾病的当前知识.
- 审查最近的指导方针建议,以管理这些处于风险的个体的失脂症.
主要方法:
- 对当前科学知识的文献综述.
- 对近期临床实践指南的分析,用于治疗脱脂症.
- 综合有关药理学药物和生活方式改变的信息.
主要成果:
- 存在多种药理选择来治疗失脂症,包括他类药物,ezetimibe,bempedoic acid,PCSK9抑制剂,n-3多不和脂肪酸和纤维酸.
- 最佳的治疗目标和药物以患者的心血管风险为指导.
- 除了药物治疗之外,改变生活方式是基本的.
结论:
- 目前的治疗策略旨在优化脂质水平,并减少糖尿病和糖尿病前期患者的心血管疾病和死亡率.
- 目前正在进行的研究和开发继续扩大胆血症的治疗选择.
关键词:
这就是为什么LDLcc LDLc有机脂性血清不良症 (atherogenic dyslipidaemia) 是一种致血性血清不良症.心血管疾病的风险.在糖尿病中,糖尿病是血糖类的.降脂药物药理学剂 降脂药物药理学剂其他非HDLcc.在糖尿病前期,糖尿病前期.治疗目标 治疗目标更多相关视频
相关概念视频
Diabetes: Management and Pharmacotherapy
283
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
283
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
661
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
661
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Overview of Lipid Metabolism
1.6K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.6K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Symptoms, Diagnosis, and Complications
539
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
539


